Author
Listed:
- Nina T. Rogers
(University of Cambridge School of Clinical Medicine)
- Steven Cummins
(Faculty of Public Health & Policy, London School of Hygiene & Tropical Medicine)
- Catrin P. Jones
(University of Cambridge School of Clinical Medicine)
- Oliver T. Mytton
(Great Ormond Street Institute of Child Health)
- Chrissy H. Roberts
(London School of Hygiene & Tropical Medicine)
- Seif O. Shaheen
(Queen Mary University of London
University of Melbourne)
- Syed Ahmar Shah
(University of Edinburgh)
- Aziz Sheikh
(University of Edinburgh
University of Oxford)
- Martin White
(University of Cambridge School of Clinical Medicine)
- Jean Adams
(University of Cambridge School of Clinical Medicine)
Abstract
Sugar sweetened beverage consumption has been suggested as a risk factor for childhood asthma symptoms. We examined whether the UK Soft Drinks Industry Levy (SDIL), announced in March 2016 and implemented in April 2018, was associated with changes in National Health Service hospital admission rates for asthma in children, 22 months post-implementation of SDIL. We conducted interrupted time series analyses (2012-2020) to measure changes in monthly incidence rates of hospital admissions. Sub-analysis was by age-group (5-9,10-14,15-18 years) and neighbourhood deprivation quintiles. Changes were relative to counterfactual scenarios where the SDIL wasn’t announced, or implemented. Overall, incidence rates reduced by 20.9% (95%CI: 29.6-12.2). Reductions were similar across age-groups and deprivation quintiles. These findings give support to the idea that implementation of a UK tax intended to reduce childhood obesity may have contributed to a significant unexpected and additional public health benefit in the form of reduced hospital admissions for childhood asthma.
Suggested Citation
Nina T. Rogers & Steven Cummins & Catrin P. Jones & Oliver T. Mytton & Chrissy H. Roberts & Seif O. Shaheen & Syed Ahmar Shah & Aziz Sheikh & Martin White & Jean Adams, 2024.
"The UK Soft Drinks Industry Levy and childhood hospital admissions for asthma in England,"
Nature Communications, Nature, vol. 15(1), pages 1-7, December.
Handle:
RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-49120-4
DOI: 10.1038/s41467-024-49120-4
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-49120-4. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.